Search Browse Earnings

IGC Pharma, Inc. — SlamSEC

IGC Pharma, Inc.

NYSE:IGC

Pharmaceutical Preparations·POTOMAC, MD

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$1.3M

+47.6% YoY

FY 2025

Adj. EBITDA

-$9.2M

-681.1% margin

FY 2025

Net Income

-$13.0M

-966.5% margin

FY 2025

EPS (Diluted)

-$0.22

FY 2025

Stock Price

$0.29

+1.4%

2026-03-09

52W Range

$0.24 – $0.50

P/E Ratio

-1.3x

Market Cap

$26.9M

Cash

$1.2M

FY 2025

Total Debt

$140,000

FY 2025

Net Cash

$1.1M

FY 2025

Enterprise Value

$25.9M

Debt / EBITDA

0.1x

FY 2025

EV / EBITDA

-2.8x

Employees

—

CEO

Mukunda Ram